PGARTPatient Global Assessment of Response to Therapy
References in periodicals archive ?
Later clinical effectiveness was evaluated during office visits using the WOMAC and PGART at weeks 2, 4, and 6.
The WOMAC and PGART are valid OA disease assessments; multiple time evaluations of therapy are clinically relevant markers of effectiveness.
PGART response at 6 weeks also showed the best response with 25 mg rofecoxib once daily.